In the News
- Engage Therapeutics Announces $23 Million Series A Financing to Advance Phase 2b Development of Novel Epileptic Seizure Rescue Therapy
- Galen US Inc. Acquires First Inhaled Therapy Approved to Treat Agitation Associated with Schizophrenia and Bipolar I Disorder, Announces Revised Labeling
- Alexza Announces U.S. Approval of ADASUVE® sNDA
ALEXZA PHARMACEUTICALS
Corporate Headquarters
2091 Stierlin Court
Mountain View, CA 94043
TEL: 650 944 7000
FAX: 650 944 7999
Email Us
Corporate Headquarters
2091 Stierlin Court
Mountain View, CA 94043
TEL: 650 944 7000
FAX: 650 944 7999
Email Us